Literature DB >> 21813776

MPYS is required for IFN response factor 3 activation and type I IFN production in the response of cultured phagocytes to bacterial second messengers cyclic-di-AMP and cyclic-di-GMP.

Lei Jin1, Krista K Hill, Holly Filak, Jennifer Mogan, Heather Knowles, Bicheng Zhang, Anne-Laure Perraud, John C Cambier, Laurel L Lenz.   

Abstract

Cyclic-di-GMP and cyclic-di-AMP are second messengers produced by bacteria and influence bacterial cell survival, differentiation, colonization, biofilm formation, virulence, and bacteria-host interactions. In this study, we show that in both RAW264.7 macrophage cells and primary bone marrow-derived macrophages, the production of IFN-β and IL-6, but not TNF, in response to cyclic-di-AMP and cyclic-di-GMP requires MPYS (also known as STING, MITA, and TMEM173). Furthermore, expression of MPYS was required for IFN response factor 3 but not NF-κB activation in response to these bacterial metabolites. We also confirm that MPYS is required for type I IFN production by cultured macrophages infected with the intracellular pathogens Listeria monocytogenes and Francisella tularensis. However, during systemic infection with either pathogen, MPYS deficiency did not impact bacterial burdens in infected spleens. Serum IFN-β and IL-6 concentrations in the infected control and MPYS(-/-) mice were also similar at 24 h postinfection, suggesting that these pathogens stimulate MPYS-independent cytokine production during in vivo infection. Our findings indicate that bifurcating MPYS-dependent and -independent pathways mediate sensing of cytosolic bacterial infections.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21813776      PMCID: PMC3159690          DOI: 10.4049/jimmunol.1100088

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

1.  Innate recognition of bacteria by a macrophage cytosolic surveillance pathway.

Authors:  Mary O'Riordan; Caroline H Yi; Ramona Gonzales; Kyung-Dall Lee; Daniel A Portnoy
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-01       Impact factor: 11.205

2.  Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta.

Authors:  C Manca; L Tsenova; A Bergtold; S Freeman; M Tovey; J M Musser; C E Barry; V H Freedman; G Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

3.  3',5'-Cyclic diguanylic acid (c-di-GMP) inhibits basal and growth factor-stimulated human colon cancer cell proliferation.

Authors:  David K R Karaolis; Kunrong Cheng; Michael Lipsky; Ahmed Elnabawi; Jennifer Catalano; Mamoru Hyodo; Yoshihiro Hayakawa; Jean-Pierre Raufman
Journal:  Biochem Biophys Res Commun       Date:  2005-04-01       Impact factor: 3.575

4.  Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population.

Authors:  Lis R V Antonelli; Antonio Gigliotti Rothfuchs; Ricardo Gonçalves; Ester Roffê; Allen W Cheever; Andre Bafica; Andres M Salazar; Carl G Feng; Alan Sher
Journal:  J Clin Invest       Date:  2010-04-12       Impact factor: 14.808

Review 5.  C-di-GMP: the dawning of a novel bacterial signalling system.

Authors:  Ute Römling; Mark Gomelsky; Michael Y Galperin
Journal:  Mol Microbiol       Date:  2005-08       Impact factor: 3.501

6.  TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection.

Authors:  Natalya V Serbina; Thais P Salazar-Mather; Christine A Biron; William A Kuziel; Eric G Pamer
Journal:  Immunity       Date:  2003-07       Impact factor: 31.745

Review 7.  Anti-cytokine therapeutics and infections.

Authors:  Charles A Dinarello
Journal:  Vaccine       Date:  2003-06-01       Impact factor: 3.641

8.  Type I interferon production enhances susceptibility to Listeria monocytogenes infection.

Authors:  Ryan M O'Connell; Supriya K Saha; Sagar A Vaidya; Kevin W Bruhn; Gustavo A Miranda; Brian Zarnegar; Andrea K Perry; Bidong O Nguyen; Timothy F Lane; Tadatsugu Taniguchi; Jeff F Miller; Genhong Cheng
Journal:  J Exp Med       Date:  2004-08-09       Impact factor: 14.307

9.  Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes.

Authors:  Victoria Auerbuch; Dirk G Brockstedt; Nicole Meyer-Morse; Mary O'Riordan; Daniel A Portnoy
Journal:  J Exp Med       Date:  2004-08-09       Impact factor: 14.307

10.  Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection.

Authors:  Javier A Carrero; Boris Calderon; Emil R Unanue
Journal:  J Exp Med       Date:  2004-08-09       Impact factor: 14.307

View more
  136 in total

1.  Crystal structures of STING protein reveal basis for recognition of cyclic di-GMP.

Authors:  Guijun Shang; Deyu Zhu; Ning Li; Junbing Zhang; Chunyuan Zhu; Defen Lu; Cuilan Liu; Qian Yu; Yanyu Zhao; Sujuan Xu; Lichuan Gu
Journal:  Nat Struct Mol Biol       Date:  2012-06-24       Impact factor: 15.369

2.  The structural basis for the sensing and binding of cyclic di-GMP by STING.

Authors:  Yi-He Huang; Xiang-Yu Liu; Xiao-Xia Du; Zheng-Fan Jiang; Xiao-Dong Su
Journal:  Nat Struct Mol Biol       Date:  2012-06-24       Impact factor: 15.369

Review 3.  Translating nucleic acid-sensing pathways into therapies.

Authors:  Tobias Junt; Winfried Barchet
Journal:  Nat Rev Immunol       Date:  2015-08-21       Impact factor: 53.106

4.  Nuclease-Resistant c-di-AMP Derivatives That Differentially Recognize RNA and Protein Receptors.

Authors:  Robert E Meehan; Chad D Torgerson; Barbara L Gaffney; Roger A Jones; Scott A Strobel
Journal:  Biochemistry       Date:  2016-02-03       Impact factor: 3.162

Review 5.  Cyclic dinucleotides and the innate immune response.

Authors:  Olga Danilchanka; John J Mekalanos
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

6.  Cyclic-di-GMP and cyclic-di-AMP activate the NLRP3 inflammasome.

Authors:  Ali A Abdul-Sater; Ivan Tattoli; Lei Jin; Andrzej Grajkowski; Assaf Levi; Beverly H Koller; Irving C Allen; Serge L Beaucage; Katherine A Fitzgerald; Jenny P-Y Ting; John C Cambier; Stephen E Girardin; Christian Schindler
Journal:  EMBO Rep       Date:  2013-09-06       Impact factor: 8.807

7.  Deletion of the cyclic di-AMP phosphodiesterase gene (cnpB) in Mycobacterium tuberculosis leads to reduced virulence in a mouse model of infection.

Authors:  Jun Yang; Yinlan Bai; Yang Zhang; Vincent D Gabrielle; Lei Jin; Guangchun Bai
Journal:  Mol Microbiol       Date:  2014-05-23       Impact factor: 3.501

8.  B Cell-Intrinsic STING Signaling Triggers Cell Activation, Synergizes with B Cell Receptor Signals, and Promotes Antibody Responses.

Authors:  Melissa M Walker; Bergren W Crute; John C Cambier; Andrew Getahun
Journal:  J Immunol       Date:  2018-10-03       Impact factor: 5.422

9.  Agonist-Mediated Activation of STING Induces Apoptosis in Malignant B Cells.

Authors:  Chih-Hang Anthony Tang; Joseph A Zundell; Sujeewa Ranatunga; Cindy Lin; Yulia Nefedova; Juan R Del Valle; Chih-Chi Andrew Hu
Journal:  Cancer Res       Date:  2016-03-07       Impact factor: 12.701

Review 10.  Intracellular pathogen detection by RIG-I-like receptors.

Authors:  Evelyn Dixit; Jonathan C Kagan
Journal:  Adv Immunol       Date:  2013       Impact factor: 3.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.